Optimization of methods and treatment conditions for studying effects of fatty acids on cell growth.
Antiproliferative properties of molecular regulators of lipid metabolism have been increasingly studied during recent years. Discussion is ongoing concerning optimal treatment conditions and assays used for monitoring proliferation and cytotoxicity. The objective of the present work was to optimize methods and treatment conditions used for studying antiproliferative effects of fatty acids and analogs, represented by palmitic acid (PA) and the beta-oxidation-restricted fatty acid analog tetradecylthioacetic acid (TTA), in rat (BT4Cn) and human (D54Mg and GaMg) glioma cell lines. Changes in [3H]thymidine incorporation preceded changes in cell number in TTA-treated glioma cell cultures, and the growth inhibition was more significantly expressed by [3H]thymidine incorporation than cell number. Addition of bovine serum albumin decreased cellular fatty acid uptake and reduced the effects of TTA and PA on [3H]thymidine incorporation. Determination of the antiproliferative effect of TTA in BT4Cn cells by MTT conversion and [3H]thymidine incorporation yielded concordant results. TTA-mediated reduction in cell number corresponded to reduction in cellular protein and total DNA content in BT4Cn cells. Reduced growth potential in TTA-treated multicellular D54Mg and GaMg spheroids supported the findings from monolayer cultures. In conclusion, cell density, treatment period, fatty acid administration, and methods for growth determination may profoundly influence the outcome of cell growth experiments. Thus, experimental conditions should be carefully controlled when performing cell growth experiments, and effects on cell growth should preferably be confirmed by different methods.
Tronstad
K J
KJ
Department of Clinical Biochemistry, University of Bergen, Haukeland Hospital, N-5021 Bergen, Norway. karl.tronstad@ikb.uib.no
Berge
K
K
Flindt
E N
EN
Kristiansen
K
K
Berge
R K
RK
D000818:Animals; D002452:Cell Count; D002455:Cell Division / Q000187:drug effects*; D004247:DNA / Q000096:biosynthesis; D005227:Fatty Acids / Q000008:administration & dosage / Q000494:pharmacology*; D005910:Glioma / Q000473:pathology; D006801:Humans; D007700:Kinetics; D019308:Palmitic Acid / Q000494:pharmacology; D011506:Proteins / Q000032:analysis; D051381:Rats; D012710:Serum Albumin, Bovine / Q000378:metabolism / Q000494:pharmacology; D012972:Sodium Hydroxide / Q000494:pharmacology; D013440:Sulfides / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D005227:Fatty Acids; D011506:Proteins; D013440:Sulfides; D012710:Serum Albumin, Bovine; D019308:Palmitic Acid; D012972:Sodium Hydroxide; C062078:1-(carboxymethylthio)tetradecane; D004247:DNA